Trademark: 79302420
Status Date
Tuesday, January 17, 2023
Registration Number
6951809
Registration Date
Tuesday, January 17, 2023
Filing Date
Monday, December 14, 2020
Published for Opposition
Tuesday, November 1, 2022
10 Hydrofluoroalkanes (HFA) powered and liquefied gas powered apparatus and instruments for use in or in relation to drug and pharmaceutical delivery devices, namely, hydrofluoroalkanes (HFA) powered drug delivery systems in the nature of infusion and injection devices for administering drugs; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors for administering pharmaceuticals and drugs and apparatus and devices for the inhalation or injection of pharmaceuticals and drugs, namely, injection needles, medical fluid auto-injectors and syringes; hydrofluoralkanes (HFA) powered catheters, transfusion sets and injection syringes for administering drugs and pharmaceuticals, and also incorporating audio, visual and/or tactile patient feedback mechanisms relating to drug and pharmaceutical delivery dosage, measuring and monitoring information; hydrofluoralkanes (HFA) powered medical syringes, medical fluid auto-injectors, drug delivery systems comprised of implantable drug delivery ports incorporating audio, visual and/or tactile patient feedback mechanisms to convey dosage, measuring, and monitoring data for the purpose of facilitating and monitoring drug and pharmaceutical delivery and administration; medical syringes; medical syringe stoppers; hydrofluoroolefin (HFO) powered medical fluid auto-injectors and medical fluid injectors; hydrofluoroolefin (HFO) powered apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; hydrofluoroolefin (HFO) powered drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; medical fluid auto-injectors; medical fluid injectors; disposable syringes and medical fluid injectors; hypodermic syringes; apparatus and devices for administering pharmaceuticals and drugs, namely, medical apparatus in the nature of infusion and injection devices for administering drugs, medical tubing for administering drugs, and hypodermic needles; sterile medical syringes and medical fluid auto-injectors for the administration of pharmaceuticals and drugs; cartridges sold empty and specially adapted for medical syringes; nozzles sold empty and specially adapted for medical syringes; drug delivery apparatus, namely, drug delivery systems comprised of drug delivery catheters and electromagnetic drug delivery apparatus for medical use; oral and nasal medication dispensers, namely, aerosol dispensers for medical use; aerosol dispensers for medical purposes; structural replacement parts and fittings for all the aforesaid goods
Feb 29, 2024
International Registration Renewed
May 16, 2023
Final Decision Transaction Processed By Ib
Apr 26, 2023
Final Disposition Notice Sent To Ib
Apr 26, 2023
Final Disposition Processed
Apr 17, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 17, 2023
Notice Of Registration Confirmation Emailed
Jan 17, 2023
Registered-Principal Register
Nov 22, 2022
New Representative At Ib Received
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 31, 2022
Notification Processed By Ib
Oct 12, 2022
Notification Of Possible Opposition Sent To Ib
Oct 12, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 23, 2022
Approved For Pub - Principal Register
Sep 8, 2022
Teas/Email Correspondence Entered
Sep 7, 2022
Correspondence Received In Law Office
Sep 7, 2022
Teas Response To Office Action Received
Apr 10, 2022
Refusal Processed By Ib
Mar 9, 2022
Notification Of Non-Final Action E-Mailed
Mar 9, 2022
Non-Final Action E-Mailed
Mar 9, 2022
Non-Final Action Written
Feb 8, 2022
Teas/Email Correspondence Entered
Feb 8, 2022
Correspondence Received In Law Office
Feb 8, 2022
Attorney Review Completed
Jan 12, 2022
Correction From Ib Entered - Attorney Review Required
Dec 17, 2021
Teas/Email Correspondence Entered
Dec 16, 2021
Correspondence Received In Law Office
Dec 16, 2021
Teas Response To Office Action Received
Nov 3, 2021
Correction Transaction Received From Ib
Jul 18, 2021
Refusal Processed By Ib
Jun 21, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 21, 2021
Refusal Processed By Mpu
Jun 12, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jun 11, 2021
Non-Final Action Written
Jun 7, 2021
Assigned To Examiner
Jan 23, 2021
Application Filing Receipt Mailed
Jan 19, 2021
New Application Office Supplied Data Entered
Jan 14, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
